SAN FRANCISCO, CA, Loyal, a clinical-stage animal health company developing lifespan extension drugs for dogs, announced that it has raised $100M in Series C funding.
Continue Reading
Sign up for FREE to read the full article and access 133K+ alternative investment headlines.